Table: begin end state 1 24 cytoplasmic 25 51 transmembrane 52 59 non-cytoplasmic 60 82 transmembrane 83 102 cytoplasmic 103 127 transmembrane 128 153 non-cytoplasmic 154 172 transmembrane 173 183 cytoplasmic 184 203 transmembrane 204 212 non-cytoplasmic 213 234 transmembrane 235 254 cytoplasmic 255 277 transmembrane 278 296 non-cytoplasmic 297 322 transmembrane 323 350 cytoplasmic 351 370 transmembrane 371 376 non-cytoplasmic 377 396 transmembrane 397 407 cytoplasmic 408 427 transmembrane 428 432 non-cytoplasmic 433 451 transmembrane 452 484 cytoplasmic
Input: >WP_092483642.1 NCBI__GCF_900115975.1:WP_092483642.1 MSVWRKKPVEQVLADKKKNKRGLVPTLGVADLTALGVGAVIGTGIFVLTGVAAANYAGPG VVFSFILSGIAATLAAMVYAELGAAIPSAGSAYTFSYVSLGEIIAWLVGWNLILEYLVAA GAVSIGWSSYMGDLLQSVGITLPAAFTSSPFDGGIVNLPAALIVLVITGLIITGTQHSTT ANKIIVVAKLAAIALFIALGVQHINPANWRPVLPYGISGVFHGAAIVFFAYIGFDAVATA SEEVKNPQRDLPRGIIWTLVISTLLYIVVAGILTGMVKYTNLNTASPVATALLRAGIPWA SALVSVGALAGLTSVLLVAMYGQSRIFFAMARDDLLPPIFDWLHPRLRTPVWDSIIIGVL VALIGAFLPIGLVAELANIGTLTAFIAVSTGAIILRRTNPDLRRPFRLPWMPAIPVLTII SAGYLAINLPPLTWVRFIAWVAIGLVVYWLYGYRKSKLARESQEVYASRAMPEPARKPED GKKV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server